Grain And Soy Allergen Mix

Grain And Soy Allergen Mix

Grain And Soy Allergen Mix Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

1.1 Patients with Generalized Lipodystrophy

MYALEPT (metreleptin) for injection is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.

Limitations of Use

  • The safety and effectiveness of MYALEPT for the treatment of complications of partial lipodystrophy have not been established.
  • The safety and effectiveness of MYALEPT for the treatment of liver disease, including nonalcoholic steatohepatitis (NASH), have not been established.
  • MYALEPT is not indicated for use in patients with HIV-related lipodystrophy.
  • MYALEPT is not indicated for use in patients with metabolic disease, including diabetes mellitus and hypertriglyceridemia, without concurrent evidence of congenital or acquired generalized lipodystrophy.

History

There is currently no drug history available for this drug.

Other Information

MYALEPT (metreleptin) for injection is a recombinant human leptin analog for injection that binds to and activates the leptin receptor. Metreleptin (recombinant methionyl-human leptin) is produced in E. coli and differs from native human leptin by the addition of a methionine residue at its amino terminus. Metreleptin is a 147-amino acid, nonglycosylated, polypeptide with one disulfide bond between Cys-97 and Cys-147 and a molecular weight of approximately 16.15 kDa.

MYALEPT is supplied as a sterile, white, solid, lyophilized cake containing 11.3 mg that is reconstituted with 2.2 mL of BWFI or WFI to a final formulation of 5 mg/mL metreleptin for subcutaneous injection. Inactive ingredients are: glutamic acid (1.47 mg/mL), glycine (20 mg/mL), polysorbate 20 (0.1 mg/mL), and sucrose (10 mg/mL), pH 4.25.

Grain And Soy Allergen Mix Manufacturers


  • Deseret Biologicals, Inc.
    Grain And Soy Allergen Mix (Adenosinum Triphosphoricum Acidum, Coumarinum, Quercetin, Rutin, Ileum (Suis), Jejunum (Suis), Stomach (Suis), Bacillus Thuringiensis (Bt Toxin), Bamboo, Barley, Eschscholzia Californica, Corn, Flax Seed, Gossypium Herbaceum, Millet, Milo, Avena Sativa, Oryza Sativa, Rye, Safflower, Sesamum, Sorghum Bicolor, Glycine Max, Saccharum, Helianthus Annuus, Wheat, Gluten, Amaranth, Natrum Sulphuricum, Sarcolacticum Acidum, Triticum Repens, Adrenocorticotrophin, Sycotic Co Bacillus) Liquid [Deseret Biologicals, Inc.]

Login To Your Free Account